Document is current

Article History

Received: 13 April 2023

Accepted: 19 June 2023

First Online: 19 July 2023

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from patients included in the study.

: A. Di Rocco received a speaker honorarium from Roche, Gilead, Janssen, and Abbvie; a grant from Takeda and Gilead; consulting fees from Roche, Takeda, Incyte, Gilead, and Novartis. M. Di Palma declares that she has no conflict of interest. G.M. D’Elia declares that she has no conflict of interest. G. Iaquinta declares that he has no conflict of interest. M. Breccia received honoraria from Novartis, Incyte, and Pfizer. F. Mancini declares that she has no conflict of interest. P. Grammatico declares that she has no conflict of interest. M. Martelli received a speaker honorarium from Roche, Gilead, Eusapharma, Incyte, Janssen-Cilag, and Beigene and a grant for the advisory board from Roche, Gilead, Novartis, Takeda, Eusapharma, Incyte, Janssen-Cilag and BMS.